TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR
Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the structures whe...
Gespeichert in:
Hauptverfasser: | , , , , , , , , , , , , , |
---|---|
Format: | Patent |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | |
container_start_page | |
container_title | |
container_volume | |
creator | DRANSFIELD, Paul John HOUZE, Jonathan MA, Zhihua DEBENEDETTO, Mikkel V LAI, Su-Jen HARVEY, James S PATTAROPONG, Vatee CHEN, Yinhong KHAKOO, Aarif Yusuf MOEBIUS, David C CHENG, Alan C KREIMAN, Charles SHARMA, Ankit SWAMINATH, Gayathri |
description | Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the structures where the definitions of the variables are provided herein. |
format | Patent |
fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2019300507A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2019300507A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2019300507A13</originalsourceid><addsrcrecordid>eNrjZLAKCfJ0jPL3cVUIiAzydIn0UXD29w3wD_VzCVZwBCJ3fz_P4JBgBX83hRAPVwXHAC-FIFdn14AQ_yAeBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIfGmxkYGhpbGBgamDuaGhMnCoAbpoqCw</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR</title><source>esp@cenet</source><creator>DRANSFIELD, Paul John ; HOUZE, Jonathan ; MA, Zhihua ; DEBENEDETTO, Mikkel V ; LAI, Su-Jen ; HARVEY, James S ; PATTAROPONG, Vatee ; CHEN, Yinhong ; KHAKOO, Aarif Yusuf ; MOEBIUS, David C ; CHENG, Alan C ; KREIMAN, Charles ; SHARMA, Ankit ; SWAMINATH, Gayathri</creator><creatorcontrib>DRANSFIELD, Paul John ; HOUZE, Jonathan ; MA, Zhihua ; DEBENEDETTO, Mikkel V ; LAI, Su-Jen ; HARVEY, James S ; PATTAROPONG, Vatee ; CHEN, Yinhong ; KHAKOO, Aarif Yusuf ; MOEBIUS, David C ; CHENG, Alan C ; KREIMAN, Charles ; SHARMA, Ankit ; SWAMINATH, Gayathri</creatorcontrib><description>Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the structures where the definitions of the variables are provided herein.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191003&DB=EPODOC&CC=US&NR=2019300507A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25562,76317</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20191003&DB=EPODOC&CC=US&NR=2019300507A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>DRANSFIELD, Paul John</creatorcontrib><creatorcontrib>HOUZE, Jonathan</creatorcontrib><creatorcontrib>MA, Zhihua</creatorcontrib><creatorcontrib>DEBENEDETTO, Mikkel V</creatorcontrib><creatorcontrib>LAI, Su-Jen</creatorcontrib><creatorcontrib>HARVEY, James S</creatorcontrib><creatorcontrib>PATTAROPONG, Vatee</creatorcontrib><creatorcontrib>CHEN, Yinhong</creatorcontrib><creatorcontrib>KHAKOO, Aarif Yusuf</creatorcontrib><creatorcontrib>MOEBIUS, David C</creatorcontrib><creatorcontrib>CHENG, Alan C</creatorcontrib><creatorcontrib>KREIMAN, Charles</creatorcontrib><creatorcontrib>SHARMA, Ankit</creatorcontrib><creatorcontrib>SWAMINATH, Gayathri</creatorcontrib><title>TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR</title><description>Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the structures where the definitions of the variables are provided herein.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLAKCfJ0jPL3cVUIiAzydIn0UXD29w3wD_VzCVZwBCJ3fz_P4JBgBX83hRAPVwXHAC-FIFdn14AQ_yAeBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIfGmxkYGhpbGBgamDuaGhMnCoAbpoqCw</recordid><startdate>20191003</startdate><enddate>20191003</enddate><creator>DRANSFIELD, Paul John</creator><creator>HOUZE, Jonathan</creator><creator>MA, Zhihua</creator><creator>DEBENEDETTO, Mikkel V</creator><creator>LAI, Su-Jen</creator><creator>HARVEY, James S</creator><creator>PATTAROPONG, Vatee</creator><creator>CHEN, Yinhong</creator><creator>KHAKOO, Aarif Yusuf</creator><creator>MOEBIUS, David C</creator><creator>CHENG, Alan C</creator><creator>KREIMAN, Charles</creator><creator>SHARMA, Ankit</creator><creator>SWAMINATH, Gayathri</creator><scope>EVB</scope></search><sort><creationdate>20191003</creationdate><title>TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR</title><author>DRANSFIELD, Paul John ; HOUZE, Jonathan ; MA, Zhihua ; DEBENEDETTO, Mikkel V ; LAI, Su-Jen ; HARVEY, James S ; PATTAROPONG, Vatee ; CHEN, Yinhong ; KHAKOO, Aarif Yusuf ; MOEBIUS, David C ; CHENG, Alan C ; KREIMAN, Charles ; SHARMA, Ankit ; SWAMINATH, Gayathri</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2019300507A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2019</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>DRANSFIELD, Paul John</creatorcontrib><creatorcontrib>HOUZE, Jonathan</creatorcontrib><creatorcontrib>MA, Zhihua</creatorcontrib><creatorcontrib>DEBENEDETTO, Mikkel V</creatorcontrib><creatorcontrib>LAI, Su-Jen</creatorcontrib><creatorcontrib>HARVEY, James S</creatorcontrib><creatorcontrib>PATTAROPONG, Vatee</creatorcontrib><creatorcontrib>CHEN, Yinhong</creatorcontrib><creatorcontrib>KHAKOO, Aarif Yusuf</creatorcontrib><creatorcontrib>MOEBIUS, David C</creatorcontrib><creatorcontrib>CHENG, Alan C</creatorcontrib><creatorcontrib>KREIMAN, Charles</creatorcontrib><creatorcontrib>SHARMA, Ankit</creatorcontrib><creatorcontrib>SWAMINATH, Gayathri</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>DRANSFIELD, Paul John</au><au>HOUZE, Jonathan</au><au>MA, Zhihua</au><au>DEBENEDETTO, Mikkel V</au><au>LAI, Su-Jen</au><au>HARVEY, James S</au><au>PATTAROPONG, Vatee</au><au>CHEN, Yinhong</au><au>KHAKOO, Aarif Yusuf</au><au>MOEBIUS, David C</au><au>CHENG, Alan C</au><au>KREIMAN, Charles</au><au>SHARMA, Ankit</au><au>SWAMINATH, Gayathri</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR</title><date>2019-10-03</date><risdate>2019</risdate><abstract>Compounds of Formula I and Formula II, pharmaceutically acceptable salt thereof, stereoisomers of any of the foregoing, or mixtures thereof are agonists of the APJ Receptor and may have use in treating cardiovascular and other conditions. Compounds of Formula I and Formula II have the structures where the definitions of the variables are provided herein.</abstract><oa>free_for_read</oa></addata></record> |
fulltext | fulltext_linktorsrc |
identifier | |
ispartof | |
issn | |
language | eng |
recordid | cdi_epo_espacenet_US2019300507A1 |
source | esp@cenet |
subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
title | TRIAZOLE PYRIDYL COMPOUNDS AS AGONISTS OF THE APJ RECEPTOR |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-13T21%3A15%3A09IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=DRANSFIELD,%20Paul%20John&rft.date=2019-10-03&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2019300507A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |